 WILMINGTON, Del., Dec. 2, 2020 PRNewswire -- BioSpecifics Technologies Corp. NASDAQ: BSTC, a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first-in-class collagenase-based product marketed as XIAFLEX in North America, today... 